1-5 of 5
Jiayuh Lin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy

Xiaojuan Wu, Yang Cao, Hui Xiao, Chenglong Li, Jiayuh Lin
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (11): 2609–2619.
https://doi.org/10.1158/1535-7163.MCT-15-0921
Published: 01 November 2016
View articletitled, Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy
Open the PDF for Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy in another window
Journal Articles

The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma

Hemant K. Bid, Doris A. Phelps, Linlin Xaio, Denis C. Guttridge, Jiayuh Lin, Cheryl London, Laurence H. Baker, Xiaokui Mo, Peter J. Houghton
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2016) 15 (5): 1018–1028.
https://doi.org/10.1158/1535-7163.MCT-15-0567
Published: 05 May 2016
View articletitled, The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma
Open the PDF for The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma in another window
Includes: Supplementary data
Journal Articles

Abstract A177: Repositioning Bazedoxifene as a novel inhibitor of IL-6/GP130 signaling for pancreatic cancer therapy

Xiaojuan Wu, Hui Xiao, Chenglong Li, Jiayuh Lin
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (12_Supplement_2): A177.
https://doi.org/10.1158/1535-7163.TARG-15-A177
Published: 01 December 2015
View articletitled, Abstract A177: Repositioning Bazedoxifene as a novel inhibitor of IL-6/GP130 signaling for pancreatic cancer therapy
Journal Articles

Abstract A223: Novel drug development approach targeting STAT3 for sarcoma therapy using MLSD and drug reposition.

Aiguo Liu, Huameng Li, Minghao Xu, Zhenjiang Zhao, Emily McWilliams, Yufang Xu, Chenglong Li, Jiayuh Lin
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): A223.
https://doi.org/10.1158/1535-7163.TARG-11-A223
Published: 12 November 2011
View articletitled, Abstract A223: Novel drug development approach targeting STAT3 for sarcoma therapy using MLSD and drug reposition.
Journal Articles

Abstract A54: STAT3 as a novel therapeutic target in human breast cancer stem cells

Li Lin, Brian Hutzen, Zhengang Peng, Huey‐Jen Lin, Pui‐Kai Li, Chenglong Li, Max Wicha, Jiayuh Lin
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A54.
https://doi.org/10.1158/1535-7163.TARG-09-A54
Published: 10 December 2009
View articletitled, Abstract A54: STAT3 as a novel therapeutic target in human breast cancer stem cells